To establish an animal model to test the function of targeting TIGIT or IL-32 against bladder cancer, we inoculated C57B6/J mice with MBT-2 cells and analyzed the colocalization of IL-32 and Treg cells. The gene discussed is TIGIT; the disease is urinary bladder cancer.